Functional Analysis of Tyrosinase Isozymes of Cultured Malignant Melanoma Cells During the Recovery Period Following Interrupted Melanogenesis Induced by Glycosylation Inhibitors  by Imokawa, Genji & Mishima, Yutaka
0022-202 X/84/8303 -0196$02.00/0 
T i-l E: JOURNAL OF l NVE:STIGATIVE: DERMi\TOLOGY, 83:1 96-201, 1984 
Copyrighl © 1984 by The Willia ms & Wilkins Co. 
Vol. 83 , No.3 
Printed in U.S.A. 
Functional Analysis of Tyrosinase Isozymes of Cultured Malignant 
Melanoma Cells During the Recovery Period Following Interrupted 
Melanogenesis Induced by Glycosylation Inhibitors* 
GENJ I IMOKAWA, PH.D. AND YUTAKA MISHIMA, M.D., PH.D. 
Department of Dermatology, Kobe Un~:ve rs ity School of Medicine, Kobe, Japan 
Multiple forms of tyrosinase, T,, T2, T ", have been 
shown to differ with respect to carbohydrate moieties of 
these isozym es. We demonstrated that, in cultured B-16 
me lanoma cells, melanization can be completely inter-
rupted by glycosylation inhibitors, such as glucosamine 
and tunicamycin, and that these inhibitors cause a selec-
tive loss of membrane-bound Ta- It is further found that 
inhibition of melanization induced by glucosamine oc-
curs even in the presence of protease inhibitors, such as 
phe nylmethy lsulfonyl fluoride and leupeptin, and that 
melanization inhibition is reversible upon removal of 
the inhibitor. In this report we have also examined the 
process of development and recovery of the tyrosinase 
isozymes in cells in which the interruption of melano-
genesis has been released by the removal of these gly-
cosylation inhibitors. The recovery process, which oc-
curs during the period after interrupted melanogenesis 
and is a process of remelanization, has been biochemi-
cally followed . Tyrosinases obtained from the deoxycho-
late-solubilized large-granule fraction of these mela-
noma cells have been analyzed by sodium dodecyl sulfate 
polyacrylamide gel e lectrophoresis. Immediately after 
removal (0 h recovery) of the glycosylation inhibitor , 
loss of melanization and T :1 is accompanied by T 1 heter-
ogeneity which is visualized as two electrophoretically 
distinct spec ies, T 1 ' and T 1". At this time, T/ and T 1" 
do not have a concanavalin A affinitive carbohydrate 
moie ty but do possess in vitro dopa reactivity . When 
recovery of melanization begins visibly 24 h later, Ta is 
r e-formed with disappearance of T1 heterogeneity. By 
48 h , the prev ious normal level of melanization is almost 
attained. These results suggest that maturation of tyro-
sinase may occur via T 1 ' and T 1" as precursors ofT:~, or 
possibly T 1 through the addition of N -glycosydically 
linked oligosaccharide moieties which can be inter-
rupted b y glucosam ine and tunicamycin. 
Recent resea rch has cons iderably inc reased our knowledge of 
the reg-ul atory mec hani sm of eumela nogenesis [1 -5 ]. One of 
our current interests has bee n th e in t racellula r maturation o l· 
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tyrosinases which is found to be close ly related to their N-
glycosydically linked oligosaccharides [6,7]. Tyrosinase has 
been reported to contain carbohydrate moieties such as sialic 
acid [8], mannose, a nd galactose [9], a nd maturation of tyro-
sinase seems to proceed from T 2 to T1 and further to T:1 with 
sequent ia l changes in their carbohydrate moiet ies as tyrosinase 
moves from ribosome to premelanosomes through such melan-
ogenic smooth membrane compartments as Golgi-associated 
endoplasmic reticulum (GERL) and coated vesicles [2] . 
ln contrast to the previous concept of early melanogenesis 
such as melanogenically active tyrosinases and premelanosome 
formation, each originating in a single functional segment, t h e 
Golgi apparatus [10], we have found that tyrosinase synt hesized 
by ribosomes becomes active through protein glycosylation and 
processing in the GERL and coated vesicles which functionally 
and structura lly are different units from t he Golgi apparatus 
[2,3]. Further, the inhibi t ion of such protein of glycosylat ion 
in cult ured melanoma cells using glucosamine [11- 14] and 
tunicamycin [15-17] has been found to result in the depigmen-
tation of these cells accompanied by the Joss of T:, tyrosinase 
and premelanosome alteration [6,7] . 
In this paper, we have made a fun ctional analysis of tyrosin-
ase isozymes by studying changes that lead to and are necessary 
for t he recovery of melanin synthesis after removal of glyco-
sy lat ion inhibition with the special a im of clarifying init ial 
melanogenesis. 
MATERIALS AND METHODS 
Materials 
Tunicamycin was obtained from Dr. Tamura of the Department of 
Agricultural Chemistry, University of Tokyo, Tokyo, J apan, through 
Dr. Kobata of the Department of Biochemistry, University of Kobe, 
Kobe, J apan. ["H]Mannose(D-[2-3H(N)]mannose, 10- 20 Ci/ mmol) and 
["C]tyrosine( L-[14C(U)]tyrosine, 450 mCi/ mmol) were purchased from 
New England Nuclear (Boston, Massachusetts). Glucosamine hydro-
chloride, dihydroxyphenylalanine, cycloheximide, and all other mate-
rials were obtained from Sigma Chemical Co (St. Louis, Missouri ). 
Cells 
B-16 mouse melanotic melanoma cells were cultured in Eagle's 
minimal essent ial medium (G ibco) supplemented with 10% fetal calf 
se rum (G ibco) , 4 mM glutamine, 100 units/ml penicillin , and 100 11g/ 
ml streptomycin, at 37•c with 5% C02/ 95% air atmosphere. Glucosa-
mine hydrochloride added at the concentration of 1 mg/ml (86.5% 
inhibition of ["H]mannose uptake [6] ) culture medium was used im-
mediately after ce ll seeding. Tunicamycin experiments were carried out 
24 h after ce ll seeding using the cu lture medium contain ing 0.2 ng/ml 
of tunicamycin (69.8% inhibition of ["Hjmannose uptake [6]). There-
after all medium was replaced with the inhibitor-containing fresh 
medium twice a week during the cell gruwth for present experiments. 
Removal of glycosylation inhibi tion was carried out afte r exposure of 
these cells to the inhibitors for 10- 25 culture days, inducing the 
complete loss of their melanization. Thus, induced unmelanized mela-
noma cells were washed 3 times with Hanks' buffer and recultured with 
fresh medium free of glycosylation inhibi tors for subsequent biochem-
ical examinations. 
Effect of Prote0-~e ln.hibit.ors: For the effect of protease inhibitors on 
glycosylation-induced depigmentation, phenylmethylsulfonyl fluoride 
(PMSF) (0.1- 5 mM) or leupeptin (LPT) (0.1 mM) was added to the 
present cul ture system together with glycosylation inhibitors, and 
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cul t ure was carried to a conf1uency. The degree of pigmentation was 
observed afte r pelleting the cells. 
Effect of Cycloheximide: Cyclohex imide was added at the concentra-
t ion of 0.05 ng/ ml immediately following removal of glycosylation 
inhibitors. 
Incorpora tion Expen:ment 
For the exa mination of the effect of drugs on the synthesis of 
carbo hydrates, cells were cultured in Falcon plastic cul ture dishes (35-
mrn diameter) containing three 15 mm -diameter glass coverslips per 
dish a nd then 1 I'Ci per ml of ["Hjmannose was added to the cultures 
fo r a desired period of time. After incubation, the cells were washed 3 
times with cold Hanks' balance solution and 5% cold trichloroacetic 
acid (TCA) was added twice every 10 min, followed by successive 
treatments with 70%, 90%, and 100% EtOH to dry the cells. The TCA-
inso luble fraction was dissolved in 0.5 ml of Soluene and mixed with 
10 ml o f to luene-based scintillat ion fluid . The radioactivity was counted 
in a liquid scintillation spectrometer. Melanogenic activity was assayed 
using incorporation of [1' Cjtyrosine (10 I'Ci/ ml) in the presence of 5 
ng/rnl of cyclohex imide in the same manner. A cell count was done 
using a hemocytometer after trypsinization. 
Fractionation 
Subcellular fractionation was performed by the method of Seiji et al 
[10) u s ing the cell homogenate from about 40 fa lcon culture dishes (75 
cm2). Thus, the cells collected after trypsinization were homogenized 
in ice-cold 0.25 M sucrose solution containing 1 mM PMSF using a 
Tefl o n homogeni zer chilled with ice. The suspension obtained was first 
cen t rifuged at 700 g for 10 min to remove un ruptured cells and nuclear 
debris. The residue was discarded. The supernata nt was further cen-
t rifuged at 12,000 g for 10 min to obtai n a soluble fraction and the 
large-granu le fraction (LGF) as a sediment. 
Sodium Dodecyl Sulfat e Polyacrylamide Gel Electrophoresis (SDS-
PAGEJ 
The LGFs from the cell homogenate were suspended in 0.5% sodium 
deoxyc holate (DOC) aqueous solu tion containing I mM PMSF for 20 
min at 4"C and were centrifuged at 105,000 g for 60 min. The DOC-
solubili zed LG F was mixed with an equal volume of buffer A (0. 125 M 
T ris-H Cl pH 6.8, 20% glycerol, 4% SDS, 0.004 % of bromphenol blue). 
T he SDS gel electrophoresis was carried out at pH 8.7 in T ris-glycine 
buffer containing 1% SDS at 1 mA per gel according to the method of 
Davis [18]. After electrophoresis, the gel was washed with 0.3 M 
phosphate buffer (PB) and then incubated in 0. 1% dopa in 0.1 M PB 
(pH 6.8) at 37"C for 5 h. 
RESULTS 
Effect of Protease Inhibitors 
In an attempt to check the possibility t hat the depigmenting 
effect by glycosylation inhibit ion is a secondary event due to 
the enhanced activity of cellular proteases, the effect of protease 
inhibitors such as PMSF (0. 1-2.5 mM) and LPT (0.1 mM) on 
glucosamine-induced depigmentat ion of B-16 melanoma cells 
was examined a fter pelleting the cells t hat had reached con-
fl uency in the presence of these protease inhibi tors. The addi-
tion of protease inhibi tors did not apparently inhibit the depig-
menting effect by glucosamine even at a concentration in which 
t be protease inhibitors partially inhibit the cell growth (Fig 1). 
Gross and Light Microscopic Observations 
The recovery process from interrupted melanogenesis in -
d u ced by the glycosylation inhibitors, glucosamine (1 mg/ ml) 
and tunicamycin (0.2 ng/ ml), can be clearly visualized afte r 
pelleting t he cells. Following the induction of pigment loss, the 
addition of fresh medium without glycosylation inhibito rs in-
duces reappearance of melanin pigment in the cells (Fig 2). 
T his recovery process of melanization begins vis ibly 2 days 
after removal of t he inhibi tors. By 3 or 4 days, the pre- inter-
rupted level of melanization is achieved with glucosamine or 
tunicamycin·treated cells, respectively. Phase contrast micro-
scopic observations of the cells that have lost and then re-
covered the pigmentatio n, indir.ate that there are no substantial 
morpho logic changes of t he cell s with t he exception of the 
c 
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F IG L Effect of protease inhibitors, LPT and PMSF on the Glc-
induced depigmentation of cultured melanoma cells. The cells were 
cultured wi th glucosamine in the presence of 0.1- 2.5 mM PMSF or 0 1 
mM LPT for 10 days. A, Cont.rol, non- t reated B-16 cells, G0, Gl~ ­
treated cell , Lpt, Glc + LPT treated cell, B, PMS, Glc + PMSF treated 
cell. 
a mounts of melanin pigment during the recovery period (Fig 
3). 
Electrophoresis 
In SDS-PAGE pat terns of t he DOC-so lubili z~d LGF from 
glucosamine-trea~ed cells , membra ne- bound T~ tyrosinase is 
lost a nd T 1 tyrosmase appears to be resolved into additional 
electrophoretic- and molecu la r weight-distinct components T ' 
and T1"· These changes in enzyme pattern occur in crluc~s~­
mine-trea ted cultures even in t he presence of protease" inhibi -
tors such as PMSF and LPT (Fig 4). By furth er illu tration 
the time·d~pendent sequence a nd pattern for this enzyme de ~ 
velopment JS shown m F1g 5. Wit hin 1 day after removal of the 
glycosylation inhibi tor, glucosamine, new melanin formation is 
not visib le. However, t he a ppearance of T 1 ' a nd T/' tyrosinases 
has a lmost disappeared . Two days after remova l of the inhibi -
tor, the ratio ofT, to T1 tyrosinase appears to resemble t hat of 
the control , a nd melanin pigmentation has been vis ibl y restored 
(Figs 5A,B, 2A, respectively ). For tunicamycin-tre~ted cells 
this pattern of T:, reappearance, T 1 ' a nd T 1" disappearance' 
a nd visualization of melanin is slightly delayed (Figs 5C D 2B, 
respectively) . ' ' ' 
Cyclohexim ide i!,j(ect 
In order to evaluate t he effect of inhibiting protein synt hesis 
during the period of recove ry of mela nogenesis, foll owing gly-
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cosylation inhibit ion, 0.05 ng/ml of cycloheximide was added 
to t he recovery system. This concentration of cycloheximide 
causes a 45% inhibi t ion of protein synthesis [6]. Our results 
demonstrated t hat in spite of a 45% inhibit ion of protein 
synthesis after the removal of glucosamine, visible melanization 
occurs, in a manner similar to that in the absence of cyclohex-
imide, within 2 days (Fig 6A) . SDS-PAGE (Fig 6B,C) shows 
that, similar to the recovery pattern present in Fig 5 in which 
a specific inhibi tor of protein synthesis was not added, T 3 
tyrosinase is clea rly re-formed with a disappearance of newly 
induced T, tyrosinases by 1 day after removal of t he glycosy-
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FIG 2. Disappearance and reappearance of melanin pigment in sus-
pensions of pelleted ce lls following glycosylation inhibitor treatment 
and the subsequent removal of the inhibitor. B-16 cells were cultured 
with the glycosylation inhibitor for 11-21 days, inducing complete loss 
of pigment and the abili ty to melanize. After the addi tion of fresh 
medium without glycosylation inhibitor, the <:ells were cultured for an 
additional 3- 4 days. A, Control, untreated B-16 cells (C) . Glucosamine 
(1 mg/ml)-treated B-16 cells on the 11th day of culture Wo) and 
subsequent treatment of these cells without glucosamine for 1 (C,), 2 
(C2l, and 3 (Co) days. 8, Control, untreated B-16 cells (C). Tunicamycin 
(0.2 ng/ml)-treated B-16 cells on the 21st day of culture (To) and 
subsequent treatment of these cells without tunicamycin for 1 ( T,), 2 
(T2), 3 (Ta), and 4 (7'4 ) days. 
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lation inhibitor. Furthermore, Fig 6D shows t hat after t he 
release from glycosylation inhibit ion and in t he presence of 
cycloheximide, the uptake of [''C]tyrosine increases concur-
rent ly with the recovery of protein glycosylation as revealed by 
the uptake of ["H]mannose. 
DISCUSSION 
The role of carbohydrate moieties in various functioning 
glycoproteins such as interferon [19], lysosome enzymes [20], 
fibronectin [21 ), and procollagen [22] has been of great interest 
to many investigators. However, the theoretically expected 
function of carbohydrate moieties of such proteins at t he cel-
lular level has not been well clarified in t he mammalian cell 
system. We have recently found that membrane-bound tyrosin -
ase (T3 ) wi t hin melanogenic compart ments is lost by glycosy-
lation inhibi t ion , which results in the loss of melanization with 
no substantial decrease in the total amoun t of tyrosinases (T~> 
T 2) [6]. One of t he key interests in melanogenesis is to clarify 
the ontogeny of the multiple forms of tyrosinases T,, T 2 , and 
T ,3 and t heir interrelated dynamics. 
Our present recovery experiments a re aimed not only at 
characterizing biochemically t he recovery phenomena of 
melanization after removal of glycosylation inhibition but a lso 
at analyzing t he initial evolution of tyrosinase isozymes t hrough 
determination of their varying melanogenic functions. Our 
present findings have revealed that between 8 and 24 h after 
removal of glucosamine or tunicamycin , T 3 tyrosinase is already 
re-formed prior to the substantial recovery of pigmentation of 
melanoma cells. This also occurs even with t he continued level 
~( 
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FIG 4. SDS-PAGE of DOC-solubilized LGF from glucosamine-
treated B-16 cells in the presence of PMSF and LPT. Tyrosinase 
activity is stained with dopa reaction after electrophoresis. Photograph 
of electrophoresis. Left: Glc-treated cell. Center: Glc-treated cells in the 
presence of 1 mM PMSF. Right: Glc-treated cells in the presence of 0.1 
mM LPT. 
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FIG 3. Light microscopic figures of B-16 cells during recovery process of melanin pigment after removal of glycosylation inhibitors. a, Control 
untreated highly melanotic B-16 cells. band c, Glucosamine-induced unpigmented B-16 cells were cultured without glucosamine for an additional 
1 or 3 days, respectively. d and e, Tunicamycin-induced unpigmented B-16 cells were cultured without tunicamycin for an additional 1 or 3 days, 
respectively. 
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of inhibited protein synthesis by cycloheximide, t hus suggesting 
that t his recovery process is glycosylation-dependent. 
Concerning t he biologic role of carbohydrate in glycoproteins, 
Bernard et al [21] reported t hat non-glycosylated fibronectin 
or IgM is more susceptible to pronase or trypsin digestion than 
are t he native counterparts in vitro. Carbohydrates are also 
considered to protect selectively a certain domain of glycopro-
tein against proteases and to promote the refolding proteins 
into a more stable and resistant conformation. However, we 
found that the addition of protease inhibitors used does not 
affect t he unmelanized process including loss of T 3 tyrosinase 
and appearance of T 1 heterogeneity, induced by glycosylation 
inhibitors. These findings do not seem to support t he proteo-
lytic conversion from glycosylation-in terrupted T 3 tyrosinase 
to T 1 tyrosinase in our case. 
Glycosylation inhibition experiments have indicated t hat T, 
tyrosinase in t he induced unmelanized cells becomes hetero -
2 3 4 
day 
T3 
Tl 
FIG 5. SDS-PAGE of DOC-solubi -
lized LGF from glycosylation inhib ito r-
treated B-16 cells during the recovery 
period following in terruption of melan-
ogenesis by glucosamine (A, B) and tun-
icamycin ( C, D). Tyrosinase activity is 
made visible with t he dopa reaction. A, 
Control, un treated B-16 ce lls (c) . Glu-
cosamine-treated B-16 cells 0, 1/.1, 1, 2, 
and 3 days of cultu re after remova l of 
glucosamine. B, Densitometoric scan of 
SDS-PAGE patterns in A. C, Tun ica-
mycin-treated B-16 cells 0, 1, 2, 3, and 4 
days of cult ure afte r removal of tunica-
mycin. D, Densitometric scan of 80S-
PAGE patterns in C. 
ge neous and consists of subclasses ofT" T,', T/', as charac-
terized by SDS electrophoresis. Further analysis throughout 
the recovery process has revealed that 8 h after removal of 
glucosamine, T3 tyrosinase is still undetectable in melanosome-
containing fraction. T, heterogeneity also cont inues to be pres-
ent, parallel to t he remaining unmelanized cells, but is found 
to de_crease 24 h after removal, almost concomitant with T:1 
tyrosmase reappearance. 
Similarly t he reversible induction of altered carbohydrate 
moieties by glucosamine has also been reported by Pan and 
Elbein [14]. They demonstrated t hat at higher concentrations 
it inhibits t he incorporation of [2-3H]mannose into functional 
viral glycoprote in in influenza virus-infected MDCK cells, re-
sul t ing in t he loss of the Glc:,MangG lcNAc2 species and in the 
appearance of a small ManaGlcNAcz species in their lipid-
linked oligosaccharides. When the cells were washed free of 
this inhibitor, they resumed synthesis of Glc3Man9GlcNAc2 
200 IMOKAWA AND MI S HIMA 
-
" ~ 
c 
' 
TJ 
Tj 
1i 
1i 
4 da' 
c D 
61 
' 
s \ I 
.. 
3 . 
2. 
I . 
Vol. 83, No.3 
/ ¢ 
t /_...•;~~-~hnnon 
0 
' l 
C ~I I O.OS )Iatml 
FIG 6. A, Reappearance of melanin pigment of t he pelleted cells in the recovery process of glycosylation inhibition where protein synthesis is 
inh ibited by cycloheximide up to 45 %. The cells were cultured with the glycosylation inhibitors for 11 days, inducing the complete loss of t heir 
melanization , and afte r the addition of fresh medium without glucosamine, were recultured in the presence of cycloheximide (0.05 ng/ ml) for a 
furth er 3- 4 days. Glucosam ine (1 mg/ml)-treated B-16 cells on the 11 th culture day (G0) and recultured B-16 cells without glucosamine in the 
presence of cyclohex imide for addi t ional 1 (G1). 2 (G.), 3 (GJ), and 4 (G,) days in comparison to those of unt reated B-16 cells (c). B and C, 
Parallel SDS gel electrophoresis from DOC-solubilized LGFs of B-16 cells which proceed in the recovery process in the presence of cycloheximide. 
B = Photograph of the electrophoresis; 0, 1, 2, 3, a nd 4 represent culture days after removal of glucosamine followed by the addition of 
cylcoheximide. C = Densitometric scan of SDS-PAGE patterns in B. D, Time course of t he recovery of tyrosine and mannose uptakes at the 
recovery process in the presence of cylcoheximide. Glucosamine (1 mg/ml)-treated B-16 cells on the 11th culture day (Go) and recultured B-16 
ce lls without glucosam ine in the presence of cycloheximide fo r additional 1 ( G1), 2 (G.), and 3 ( G3) days. 
species and Man:~G icNAc2 disappeared. Our newly observed T1' 
and T 1" tyrosinases which lost concanavalin A affi ni t ive car-
bohydrate mo iety [23] but still retained dopa reactivity may be 
t he result of the interrupted maturation of T 1 tyrosinase. They 
a re possibly T,, precursors or pre-T:~ subuni ts because of the 
prompt or almost concomitant recove ry ofT:, and of T1 homo-
ge neity . lt seems reasonable to assume that t hese inhibito rs 
visualize the normally nonappare nt and tra nsit function al seg-
ments of the tyrosinase maturation process which is normally 
a coordinated physiologic process. 
Although why such biphasic and interrelated phenomena of 
ty rosinases after glycosylation inhibit ion occur is not yet com-
pletely understood, it may indicate t hat t here are two kinds of 
functional carbohydrate units in tyrosinase molecules: (1) 
br idge carbohydrates, which bind to Lhe premelanosomal mem-
brane and a re a melanogenic fun ctiona l core, and a re found to 
be selectively interrupted in their synthesis by t unicamycin: 
and (2) non-bridge carbohydrates whose synthesis is relatively 
tunicamycin insensitive. Induced heterogeneity of T 1 tyrosi-
nases (T1', T1 ") may be due to the interrupted synthesis of 
t hese bridge carbohydrates. These new T, spec ies are electro-
phoretically identical to but different in molecular weight from 
the original T, tyrosinase. Although it has been considered by 
some [24,25] that T 3 tyrosinase is merely a membrane-bound 
form of T , tyrosinase, our avai lable evidence suggests that 
t here appear to be additional biologic propert ies in T 3 tyrosin-
ase which are essent ial for melanization and for which N-
glycosiclically linked oligosaccharides play an integral role. 
Hearing, Kornor, and Pawelek [5] have recently reported 
different ial functions of multiple forms of tyrosinases in the 
melanogenesis pathway. Soluble tyrosinase (T,) contains block-
ing factor activity which retards the conversion of 5,6-clihy-
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droxyindole into melanin, while membrane-bound tyros inase 
T a found in melanosomes conta ins activity t hat accelerates 
melanin formation from dopachrome. These facts are essen-
t ially in agreement with ou r findings describing a function of 
the carbohydrate moieties of T:1 tyrosinase necessary for in vivo 
melanization. 
It may be concluded that t he initiation of melanization 
requires the recovery of T:1 tyrosinase within melanosomes 
which is accompanied by t he increased uptake of man nose and 
re-formation of normally structured melanosomes.t Although 
we cannot definitely rule out the possibility that re-formation 
of the T:1 tyrosi nase occurs independently of the disappearance 
of T 1 tyrosinase heterogeneity , evidence obtained here seems 
to s u ggest t hat maturation of tyrosinase occurs from T 1 seg-
ments to T1 t-yrosinase primarily by the addit ion of N-glyco-
sidically linked oligosaccharide moieties which are clearly 
shown to be functional units of melanization within melano-
somes. 
t Imokawa G, Mishima Y: Intrace llular dynamics of tyrosinases and 
premelanosomes during recovery of glycosylation inhibition in cultured 
B -16 melanoma cells. In preparation. 
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